We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Attys Want $47M From $166M Lidoderm Pay-For-Delay Deal

Law360 (June 12, 2018, 4:42 PM EDT) -- Attorneys for the direct purchasers of the Lidoderm pain patch urged a California federal judge to approve more than $47 million in attorneys' fees and reimbursements Monday out of a $166 million settlement with pharmaceutical companies Teikoku, Endo and Actavis.

After securing the settlement in March, the attorneys for the class argued that the amount, which includes more than $2 million in reimbursements, was “a justified departure” from a 25 percent benchmark. The motion comes as the litigation over the alleged pay-for-delay arrangement between the three companies...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.